POTELIGEO FDA approval date

The FDA approved POTELIGEO on 8 Aug 2018.

FDA approval date
8 Aug 2018

Drug identity has not yet been verified against registry records

Also recorded as MOGAMULIZUMAB-KPKC

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-08-08DayPOTELIGEOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761051", "applicant_as_listed_by_fda": "KYOWA KIRIN", "brand_names": ["POTELIGEO"], "active_ingredients": ["MOGAMULIZUMAB-KPKC"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20180808", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026